D3A.025
Benign carcinoid tumor of the sigmoid colon
Clinical Classification Guidelines
Medical Intelligence & Overview
A benign carcinoid tumor of the sigmoid colon is a type of slow-growing, non-cancerous growth that originates from neuroendocrine cells in the sigmoid part of the large intestine. These tumors are part of the carcinoid tumors category, which can occur in various parts of the body but are notably found in the gastrointestinal tract. While benign, these tumors require medical evaluation to monitor and manage their presence effectively.
Causes & Symptoms
Clinical Causes: Genetic factors that predispose individuals to neuroendocrine tumors Genetic syndromes such as Multiple Endocrine Neoplasia (MEN) type 1 and other familial syndromes Environmental factors like exposure to certain chemicals or carcinogens Chronic inflammation of the intestines, which may contribute to abnormal cell growth Unknown factors, as the exact cause of these benign tumors often remains unclear
Key Symptoms: No noticeable symptoms in many cases, especially when the tumor is small Changes in bowel habits, such as constipation or diarrhea Abdominal pain or discomfort, particularly in the lower abdomen Rectal bleeding or blood in the stool A feeling of incomplete bowel evacuation Nausea or vomiting if the tumor causes partial bowel obstruction Unexplained weight loss in some cases
Diagnostic & Treatment
Diagnosis Path: Endoscopy or colonoscopy: Allows direct visualization and biopsy of the tumor Imaging studies such as CT scans, MRI, or somatostatin receptor scintigraphy to determine tumor location and size Biopsy: Laboratory analysis of tissue samples to confirm benign neuroendocrine tumor Blood and urine tests: May identify hormone levels or markers associated with neuroendocrine activity
Treatment Protocols: Surveillance: Regular monitoring through surveillance colonoscopies and imaging for small, asymptomatic tumors Surgical removal: Polypectomy or resection of the tumor to prevent potential growth or complications Endoscopic techniques: Minimally invasive removal methods in suitable cases Pathological assessment post-removal: To confirm benign nature and ensure complete excision Follow-up care: Periodic evaluation to monitor for recurrence or development of additional tumors
Clinical Advice & FAQs
Billing Guidance
Is D3A.025 a billable ICD-10 code?
Yes, D3A.025 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D3A.025?
Clinical documentation must specify the nature of Benign carcinoid tumor of the sigmoid colon and any associated comorbidities for accurate reporting.
Cite this Clinical Reference